The Anti-CD164 Chimeric Recombinant Rabbit Monoclonal Antibody (HDAB0302) is a cutting-edge research tool for scientists studying CD164, a key cell surface marker involved in immune regulation and cell adhesion processes. This antibody, developed using advanced recombinant technology and raised in rabbits, offers high specificity and sensitivity in detecting CD164 protein expression in various human samples.With its proven efficacy in Western blot applications, this monoclonal antibody is essential for analyzing CD164 levels and distribution in different cell types, particularly in studies related to immunology and cancer research. By targeting CD164, researchers can gain valuable insights into its role in immune cell signaling pathways and its potential as a therapeutic target for treating immune-related disorders and malignancies.
The Anti-CD164 Chimeric Recombinant Rabbit Monoclonal Antibody (HDAB0302) provides a reliable tool for investigating the functional mechanisms of CD164 and its implications in disease pathogenesis. Its specificity and reproducibility make it an indispensable asset for unraveling the complex interplay between CD164 and immune responses, offering new avenues for developing innovative treatments and therapies in the field of biomedicine.
SKU:
HDAB0302
Size:
100 µg
Clonality:
Monoclonal
Clone:
DMC476
Synonyms:
LMOR; M-OR-1; MOP; MOR; MOR1; OPRM
Applications:
Flow Cyt
Recommended Dilution:
Flow Cyt 1:100
Host Species:
Rabbit
Isotype:
Rabbit/Human Fc chimeric IgG1
Reactivity:
Human
Purification Method:
Purified from cell culture supernatant by affinity chromatography
Formulation:
Powder
Buffer:
1XPBS
Storage:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Usage:
Research use only
Background:
This gene encodes one of at least three opioid receptors in humans; the mu opioid receptor (MOR). The MOR is the principal target of endogenous opioid peptides and opioid analgesic agents such as beta-endorphin and enkephalins. The MOR also has an important role in dependence to other drugs of abuse, such as nicotine, cocaine, and alcohol via its modulation of the dopamine system. The NM_001008503.2:c.118A>G allele has been associated with opioid and alcohol addiction and variations in pain sensitivity but evidence for it having a causal role is conflicting. Multiple transcript variants encoding different isoforms have been found for this gene. Though the canonical MOR belongs to the superfamily of 7-transmembrane-spanning G-protein-coupled receptors some isoforms of this gene have only 6 transmembrane domains. [provided by RefSeq, Oct 2013]
